These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17885523)

  • 21. The role of tilt training in preventing recurrent syncope in patients with vasovagal syncope: a prospective and randomized study.
    Duygu H; Zoghi M; Turk U; Akyuz S; Ozerkan F; Akilli A; Erturk U; Onder R; Akin M
    Pacing Clin Electrophysiol; 2008 May; 31(5):592-6. PubMed ID: 18439174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective evaluation of non-pharmacological treatment in vasovagal syncope.
    Romme JJ; Reitsma JB; Go-Schön IK; Harms MP; Ruiter JH; Luitse JS; Lenders JW; Wieling W; van Dijk N
    Europace; 2010 Apr; 12(4):567-73. PubMed ID: 20047924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of recurrent neurocardiogenic syncope with cardiac inhibitors with ipratropium bromide].
    Friederich HC; Michaelsen J; Hesse C; Schellberg D; Schwab M; Herzog W
    Z Kardiol; 2004 Jun; 93(6):479-85. PubMed ID: 15252742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pacing for neurally-mediated syncope: How to decide?
    Brignole M
    Cardiol J; 2014; 21(6):601-5. PubMed ID: 25524729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of sinus and atrioventricular nodes function in patients with vasovagal syncope.
    Pietrucha AZ; Wnuk M; Wojewódka-Zak E; Wegrzynowska M; Mroczek-Czernecka D; Bzukała I; Konduracka E; Piwowarska W
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S158-62. PubMed ID: 19250083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tilt training: does it have a role in preventing vasovagal syncope?
    Gurevitz O; Barsheshet A; Bar-Lev D; Zimlichman E; Rosenfeld GF; Benderly M; Luria D; Amital H; Kreiss Y; Eldar M; Glikson M
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1499-505. PubMed ID: 18070305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized comparison of metoprolol versus conventional treatment in preventing recurrence of vasovagal syncope in children and adolescents.
    Zhang Q; Jin H; Wang L; Chen J; Tang C; Du J
    Med Sci Monit; 2008 Apr; 14(4):CR199-203. PubMed ID: 18376348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis and treatment of syncope].
    Mehlsen J; Mehlsen AB
    Ugeskr Laeger; 2008 Feb; 170(9):718-23. PubMed ID: 18307957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The economics of treating vasovagal syncope.
    Sutton R; Petersen ME
    Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 2):849-50. PubMed ID: 9080526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Learning needs of patients with vasovagal syncope.
    White WD; Sheldon RS; Ritchie DA
    Can J Cardiovasc Nurs; 2003; 13(1):26-30. PubMed ID: 12703103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting recurrence of vasovagal syncope: a simple risk score for the clinical routine.
    Aydin MA; Maas R; Mortensen K; Steinig T; Klemm H; Risius T; Meinertz T; Willems S; Morillo CA; Ventura R
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):416-21. PubMed ID: 19017338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardioinhibitory carotid sinus hypersensitivity predicts an asystolic mechanism of spontaneous neurally mediated syncope.
    Maggi R; Menozzi C; Brignole M; Podoleanu C; Iori M; Sutton R; Moya A; Giada F; Orazi S; Grovale N
    Europace; 2007 Aug; 9(8):563-7. PubMed ID: 17507364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized clinical trials of neurally mediated syncope.
    Brignole M
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S64-9. PubMed ID: 12950522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The intravenous adenosine test: a new test for the identification of bradycardia pacing indications? A pilot study in subjects with bradycardia pacing indications, vasovagal syncope and controls.
    Parry SW; Chadwick T; Gray JC; Bexton RS; Tynan M; Bourke JP; Nath S
    QJM; 2009 Jul; 102(7):461-8. PubMed ID: 19468041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Controversies in the conduction and evaluation of clinical trials results for the treatment in vasovagal syncope].
    Gajek J; Zyśko D; Halawa B
    Pol Merkur Lekarski; 2003 May; 14(83):464-7. PubMed ID: 12939829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective evaluation of psychological distress and psychiatric morbidity in recurrent vasovagal and unexplained syncope.
    D'Antono B; Dupuis G; St-Jean K; Lévesque K; Nadeau R; Guerra P; Thibault B; Kus T
    J Psychosom Res; 2009 Sep; 67(3):213-22. PubMed ID: 19686877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurocardiogenic, vasovagal syncope.
    Ector H
    Eur Heart J; 1999 Dec; 20(23):1686-7. PubMed ID: 10562472
    [No Abstract]   [Full Text] [Related]  

  • 38. Value of symptoms to predict tilt testing outcome in patients with clinical suspicion of vasovagal syncope.
    Vallejo M; Hermosillo AG; Márquez MF; Urquidez AK; Sotomayor A; Salas E; Cárdenas M
    Arch Med Res; 2007 Jul; 38(5):579-83. PubMed ID: 17560466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic approach to patients with neurocardiogenic syncope].
    Zyśko D; Gajek J; Halawa B
    Pol Merkur Lekarski; 2004 Nov; 17(101):503-6. PubMed ID: 15754644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence-based treatment for vasovagal syncope.
    Kuriachan V; Sheldon RS; Platonov M
    Heart Rhythm; 2008 Nov; 5(11):1609-14. PubMed ID: 18984541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.